Silica as a Polishing Agent: How It Works and Where It Is Used

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Silica Supplier Thailand: Market Overview and Sourcing Options
  • Keywords: silica exporter
  • Published: 2026-11-20 00:35:40
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Mesoporous carriers also offer an attractive alternative in the oral therapy of macromolecules rather than the more complicated parenteral administration. Peptides and proteins may denature in the greatly acidic environment of the stomach, lose their structure and function [ 1, 13 ], while the proteases in the digestive system break down the protein chains, making the molecule useless and the therapy ineffective [ 1, 13, 91 ]. Additionally, poor permeation through the epithelium is another hindering component during the oral administration of macromolecules [ 1, 13 ]. The macromolecule locked inside the pores stays protected against enzymatic or chemical degradation, and its permeation through the epithelium can also be improved [ 1, 13, 91 ]. It is also true that smaller pores deliver better protection for macromolecules against degradation [ 1 ]. Mesoporous silica nanocarriers have extra intriguing advantages because of their special properties that make them outstanding over other carriers and therefore provide a popular alternative in formulating macromolecules [ 1, 13 ].

Silica Market Trends 2026: Demand Drivers, Technologies and Regional Outlook

Quartz CAS 14808-60-7: Identification, Hazards and Regulatory Information
100. Karaman D.Ṣ., Patrignani G., Rosqvist E., Smått J.-H., Orłowska A., Mustafa R., Preis M., Rosenholm J.M. Mesoporous silica nanoparticles facilitating the dissolution of poorly soluble drugs in orodispersible films. Eur. J. Pharm. Sci. 2018;122:152-159. doi: 10.1016/j.ejps.2018.06.027. [ DOI ] [ PubMed ] [ Google Scholar ]
Silica Powder Malaysia: Suppliers, Grades and Sourcing Options
2.1. Particle Size
Silica MSDS: How to Read It and What Safety Information to Check
What Is Quartz Powder? Production, Particle Sizes, Purity Grades and Uses

What Is Silica Aerogel? Structure, Thermal Performance and Insulation Applications

What is silica (SiO₂)?

quartz powder for ceramics Even though MSNs can usually be recognized as secure products, their use during therapy may cause side impacts in the body [ 1, 2, 29 ]. Due to their small size and large surface area, they may tend to accumulate in the body, or certain organs (liver, spleen, kidney, lung) and may even be toxic in higher concentrations, which is a clear disadvantage [ 1, 4, 27 ]. The silanol groups (Si-OH) on their surface can interact with the phospholipid layer of the cell membrane, thereby causing cell lysis or, in extreme cases, hemolysis [ 4, 8 ]. In severe cases, the lack of hemocompatibility can also cause issues [ 2 ]. Overall, indications of cytotoxicity, haemotoxicity, and genotoxicity were also found [ 4, 8 ]. That is why the biocompatibility of all comparable preparations must be strictly controlled [ 2, 4, 27 ]. The physicochemical features (particle size, particle morphology, surface chemistry, pore structure, etc.) of nanocarriers also have a major impact on toxicity [ 2, 4, 8, 30 ]. Additionally, further attention must be paid to the biological influences of their decomposition products, because they may also cause unwanted side influences [ 1 ]. The breakdown of silica nanoparticles in the body can take up to a few days. The opening hydration is followed by hydrolysis, and, in the end, they are excreted in the urine in the form of silicic acid [ 1 ]. Nevertheless, the literature is contradictory in this regard [ 31 ]. Some experiments show no considerable cytotoxic effect [ 18, 31 ], while other experiments say otherwise [ 23, 32 ]. For example, an in vitro study was performed with multiple concentrations, surfaces, and particle sizes (60 nm, 100 nm, 300 nm) of MSNs, with an exposure time of 72 h [ 18 ]. This study shown no significant cytotoxic influence in any of the cell lines tested (human cervical (HeLA), epithelial lung (A549), and glioblastoma (U251)) [ 18 ]. Ismail et al. investigated the cytotoxic effect of silica nanoparticles in vivo in mouse models [ 33 ]. Amorphous silica nanoparticles were administered to the animals orally, at a dose of 150 mg/kg/day, for 3 months. Based on these mouse models, no toxic effects were detected under sub-chronic treatment of the nanoparticles [ 31 ]. In another study, particle size (15 nm, 60 nm, 200 nm) dependent impact was observed on cellular viability in all four cell lines tested (THP-1 derived macrophages, A549 epithelial cells, HaCaT keratinocytes, and NRK-52E kidney cells) [ 23 ]. Smaller particles caused notable toxicity on each cell line, after the exposure time of 24 h, in contrast to the larger particles, which demonstrated no cytotoxic impact [ 23 ]. A comparable outcome has been published to verify the toxic characteristic of mesoporous silica. In this in vitro study, the researchers investigated the effect of MSNs with an average size of 7 nm on cell viability at three different concentrations. After 72 h of exposure, only the highest concentration (62.5 µg/mL) caused a substantial decrease in cell viability of human lung fibroblast cells. This toxicity occurred in a time- and dose-dependent manner [ 32 ]. In an in vivo mouse model, MacCuaig et al. presented coating-dependent impacts after repeated intravenous administration of MSNs. Chitosan-coated MSNs induced minor organ changes and were the most biocompatible. Uncoated and especially PEG-coated MSNs (especially 2K PEG) moderately augmented pre-existing vascular or organ lesions, implying that PEGylation has the potential to augment chronic risks, while chitosan enables safer long-term use [ 34 ]. An in vitro study of Barguilla et al. exposed epithelial lung cells to bare, PEG-functionalized, or galacto-oligosaccharide-functionalized MSNs for eight weeks. There was no reported long-term DNA damage, but malignant-like alterations like anchorage-independent growth, boosted migration/invasion, and secretome-facilitated tumor promotion were triggered by PEG- and GAL-functionalized MSNs. Naked MSNs did not cause such alterations and were determined to be safer [ 35 ]. Coating, on the whole, exerts a significant impact on the safety of MSNs. Uncoated MSNs are relatively innocuous; the most biocompatible coatings were achieved with chitosan, but PEG and carbohydrate functionalization can be dangerous in the long run, from vascular toxicity in vivo to tumor-promoting activity in vitro [ 34, 35 ].

What is the difference between fumed silica and precipitated silica?

silica for battery separator This equation fits especially well for premature release, up to 60% of the drug released, when there is no change in the matrix system during the release process. From a perspective of pore geometry, it basically controls drug release rates by affecting effective diffusion pathways. Boosted complexity of geometries raises tortuosity and reduces effective diffusion. High tortuosity and low pore connectivity cut down drug diffusion, consequently lowering the release rates. Furthermore, surface roughness and pore size distribution affect surface region, diffusion, and residence times, and thereby drug release kinetics. Thus, coupling the Fick diffusion model with parameters characterizing pore geometry (e.g., porosity, tortuosity, etc.) enables for more precise and automatic modeling of drug release kinetics. In this way, it is nicely clarified why release profiles differ for chemically comparable matrices due to differences in their geometrical shapes [ 59, 60 ].

What drives silica raw material prices?

silica food additive 6.2. Perks of MSNs in Diverse Administration Routes

Cite this article: Silica Raw Materials News. "Fumed Silica Manufacturer: Production Process, Key Grades and How to Choose ." Published 2026-11-20 00:35:40. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.